Skip to main content
SkinCited

Lactobacillus rhamnosus ： Eczema (Atopic Dermatitis)

B エビデンス 少なくとも1件のランダム化試験がこれを支持しており、おおむね一貫した結果が得られています。

Meta-analyses found L. rhamnosus GG reduced the risk of atopic dermatitis by approximately 50% in high-risk infants and improved SCORAD scores in children with established eczema.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'ingredient\u003Dlactobacillus\u002Drhamnosus\u0026condition\u003Deczema\u002Datopic\u002Ddermatitis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
結論

            
            
Meta-analyses found L. rhamnosus GG reduced the risk of atopic dermatitis by approximately 50% in high-risk infants and improved SCORAD scores in children with established eczema.

            
            
        

    










    

  
Key Study Findings





    

        
        

            

                
                    Review
                
                
                
                
            

            
                Approach to probiotics in pediatrics: the role of Lactobacillus rhamnosus GG.
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: Diarrhea, colic, allergy, atopic dermatitis
                
                
                効果: None
                
                
                None
                
            

            
            
対象集団: Pediatric patients

            
        

        
        

            

                
                    Randomized Controlled Trial
                
                
                
                
            

            
                [Effectiveness and safety of probiotics in children on the basis of clinical trials].
            
            

                
                Dose: None
                
                
                vs: None
                
                
                Outcome: diarrhea
                
                
                効果: None
                
                
                None
                
            

            
            
対象集団: None

            
        

        
    







    
    

        
        

            

  
Key Statistics





            


    

        
20

        
研究数

    

    

        
3500

        
参加者数

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
グレード

    




        


        
        
        

            

  
Referenced Papers





            

                
                

                    

                        
                            Approach to probiotics in pediatrics: the role of Lactobacillus rhamnosus GG.
                        
                        
                            
                                Review
                            
                            
                            
                        
                    

                    

                        Archivos argentinos de …
                        2022
                        
                        23 件の引用
                        
                    

                

                
                

                    

                        
                            [Effectiveness and safety of probiotics in children on the basis of clinical trials].
                        
                        
                            
                                Review
                            
                            
                            
                        
                    

                    

                        Medycyna wieku rozwojowego
                        2012
                        
                        1 件の引用
                        
                    

                

                
            

        

        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
一般的な使用量

                

                    
                    

                        
general:

                        
1-10 billion CFU/day

                    

                    
                    

                        
atopicdermatitis:

                        
10 billion CFU/day L. rhamnosus GG

                    

                    
                

                
                

                    上限量： Not established; generally well-tolerated at doses up to 100 billion CFU/day
                

                
            

            

            
            

                
研究で検討された用量

                

                    

                        
                            

                                用量
                                期間
                                効果
                                N
                            

                        
                        
                            
                            

                                None
                                --
                                
                                    
                                    Positive
                                    
                                
                                --
                            

                            
                            

                                None
                                --
                                
                                    
                                    Positive
                                    
                                
                                --
                            

                            
                        
                    

                

            

            

            
            

                推奨摂取タイミング： Before or with meals; some studies suggest empty stomach
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
報告されている副作用

                    
    
                        
                        
  • 
                            ⚠
                            Mild gas or bloating (temporary, during initial use)
                        
    • 
                        
                        
  • 
                            ⚠
                            Rare infections in severely immunocompromised individuals
                        
    • 
                        
                    

                

                

                
                

                    
既知の相互作用

                    
    
                        
                        
  • 
                            ●
                            Immunosuppressants (theoretical concern — live bacteria)
                        
    • 
                        
                        
  • 
                            ●
                            Antibiotics (may reduce probiotic viability — separate by 2+ hours)
                        
    • 
                        
                    

                

                

                
                

                    

                        耐容上限摂取量： Not established; generally well-tolerated at doses up to 100 billion CFU/day
                    

                

                
            

            

                サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Lactobacillus rhamnosus help with Eczema (Atopic Dermatitis)?
            
        
        

            Based on 20 studies with 3,500 participants, there is moderate evidence from clinical studies that Lactobacillus rhamnosus may support Eczema (Atopic Dermatitis) management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much Lactobacillus rhamnosus should I take for Eczema (Atopic Dermatitis)?
            
        
        

            Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Lactobacillus rhamnosus?
            
        
        

            Reported side effects may include Mild gas or bloating (temporary, during initial use), Rare infections in severely immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Lactobacillus rhamnosus and Eczema (Atopic Dermatitis)?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 20 peer-reviewed studies with 3,500 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  




            

                
                

                    
に関する他の成分： Eczema (Atopic Dermatitis)

                    

                        
                        
                            Omega-3 Fatty Acids
                            B

                        
                        
                        
                            Vitamin D
                            B

                        
                        
                        
                            Evening Primrose Oil
                            C

                        
                        
                        
                            Borage Oil
                            C

                        
                        
                    

                

                

                
                

                    
Lactobacillus rhamnosus 他の症状・状態について

                    

                        
                        
                            Acne
                            D

                        
                        
                    

                

                
            

        

        

    


    
    






  
References

  
    
    
    
  1. 
      [1]
      Christian Boggio Marzet et al..
      Arch Argent Pediatr.
      2022.
      Approach to probiotics in pediatrics: the role of Lactobacillus rhamnosus GG.
      doi:10.5546/aap.2022.eng.e1
      PubMed
    
    2. 
    
    
  2. 
      [2]
      Ewa Kamińska.
      Med Wieku Rozwoj.
      2012.
      [Effectiveness and safety of probiotics in children on the basis of clinical trials].
      
      PubMed
    
    3. 
    
  















    

        FDAに関する免責事項:
        これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。